BioLineRx Ltd., a clinical-stage biopharmaceutical company focused on oncology, announced it will release its unaudited financial results for the quarter ended June 30, 2019 on Tuesday, August 6, 2019, before the US markets open.
July 30, 2019
· 2 min read